Literature DB >> 19124433

Systemic and uteroplacental renin--angiotensin system in normal and pre-eclamptic pregnancies.

Lauren Anton1, K Bridget Brosnihan.   

Abstract

Pregnancy is characterized by an increase in many of the different components of the circulating renin-angiotensin system (RAS). However, the physiological mechanisms of stimulated RAS activity during pregnancy are unknown. Even less understood is how this system may be altered in pre-eclampsia, a hypertensive disorder of pregnancy. Additional studies have shown the presence of a local tissue specific RAS in the uteroplacental unit of normal and pre-eclamptic pregnancies. Differences in normal pregnant and pre-eclamptic RAS component regulation may provide insight into the mechanisms responsible for the clinical pathological features of pre-eclampsia. Specifically, this review summarizes the key findings in the circulating and uteroplacental RAS in normal and pre-eclamptic pregnancies.

Entities:  

Mesh:

Year:  2008        PMID: 19124433      PMCID: PMC2692864          DOI: 10.1177/1753944708094529

Source DB:  PubMed          Journal:  Ther Adv Cardiovasc Dis        ISSN: 1753-9447


  90 in total

1.  Alternative production pathways of angiotensins and differential cardiovascular remodelling.

Authors:  Giampiero Bricca
Journal:  J Hypertens       Date:  2002-10       Impact factor: 4.844

2.  Pregnancy enhances the angiotensin (Ang)-(1-7) vasodilator response in mesenteric arteries and increases the renal concentration and urinary excretion of Ang-(1-7).

Authors:  Liomar A A Neves; Aleck F Williams; David B Averill; Carlos M Ferrario; Michael P Walkup; K Bridget Brosnihan
Journal:  Endocrinology       Date:  2003-08       Impact factor: 4.736

3.  Urinary vasodilator and vasoconstrictor angiotensins during menstrual cycle, pregnancy, and lactation.

Authors:  G Valdés; A M Germain; J Corthorn; C Berrios; A C Foradori; C M Ferrario; K B Brosnihan
Journal:  Endocrine       Date:  2001-11       Impact factor: 3.633

4.  Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase.

Authors:  Chad Vickers; Paul Hales; Virendar Kaushik; Larry Dick; James Gavin; Jin Tang; Kevin Godbout; Thomas Parsons; Elizabeth Baronas; Frank Hsieh; Susan Acton; Michael Patane; Andrew Nichols; Peter Tummino
Journal:  J Biol Chem       Date:  2002-01-28       Impact factor: 5.157

5.  Angiotensin-(1-7) in normal and preeclamptic pregnancy.

Authors:  David C Merrill; Michael Karoly; Kai Chen; Carlos M Ferrario; K Bridget Brosnihan
Journal:  Endocrine       Date:  2002-08       Impact factor: 3.633

6.  AT1 receptor agonistic antibodies from preeclamptic patients stimulate NADPH oxidase.

Authors:  Ralf Dechend; Christiane Viedt; Dominik N Müller; Bernhard Ugele; Ralf P Brandes; Gerd Wallukat; Joon-Keun Park; Jurgen Janke; Peter Barta; Jurgen Theuer; Anette Fiebeler; Volker Homuth; Rainer Dietz; Hermann Haller; Jörg Kreuzer; Friedrich C Luft
Journal:  Circulation       Date:  2003-02-24       Impact factor: 29.690

7.  Possible activation of the renin-angiotensin system in the feto-placental unit in preeclampsia.

Authors:  Mitsuaki Ito; Atsuo Itakura; Yasumasa Ohno; Masao Nomura; Takeshi Senga; Tetsuro Nagasaka; Shigehiko Mizutani
Journal:  J Clin Endocrinol Metab       Date:  2002-04       Impact factor: 5.958

8.  Angiotensin-converting enzyme 2 is an essential regulator of heart function.

Authors:  Michael A Crackower; Renu Sarao; Gavin Y Oudit; Chana Yagil; Ivona Kozieradzki; Sam E Scanga; Antonio J Oliveira-dos-Santos; Joan da Costa; Liyong Zhang; York Pei; James Scholey; Carlos M Ferrario; Armen S Manoukian; Mark C Chappell; Peter H Backx; Yoram Yagil; Josef M Penninger
Journal:  Nature       Date:  2002-06-20       Impact factor: 49.962

9.  Enhanced renal immunocytochemical expression of ANG-(1-7) and ACE2 during pregnancy.

Authors:  K Bridget Brosnihan; Liomar A A Neves; JaNae Joyner; David B Averill; Mark C Chappell; Renu Sarao; Josef Penninger; Carlos M Ferrario
Journal:  Hypertension       Date:  2003-07-21       Impact factor: 10.190

10.  Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas.

Authors:  Robson A S Santos; Ana C Simoes e Silva; Christine Maric; Denise M R Silva; Raquel Pillar Machado; Insa de Buhr; Silvia Heringer-Walther; Sergio Veloso B Pinheiro; Myriam Teresa Lopes; Michael Bader; Elizabeth P Mendes; Virgina Soares Lemos; Maria Jose Campagnole-Santos; Heinz-Peter Schultheiss; Robert Speth; Thomas Walther
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-26       Impact factor: 11.205

View more
  27 in total

Review 1.  Pregnancy and the endocrine regulation of the baroreceptor reflex.

Authors:  Virginia L Brooks; Roger A L Dampney; Cheryl M Heesch
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-05-26       Impact factor: 3.619

2.  Different effects of tocolytic medication on blood pressure and blood pressure amplification.

Authors:  Isabelle Fabry; Peter De Paepe; Jan Kips; Sebastian Vermeersch; Luc Van Bortel
Journal:  Eur J Clin Pharmacol       Date:  2010-11-16       Impact factor: 2.953

3.  Associations of ACE I/D, AGT M235T gene polymorphisms with pregnancy induced hypertension in Chinese population: a meta-analysis.

Authors:  Ming Zhu; Jie Zhang; Shaofa Nie; Weirong Yan
Journal:  J Assist Reprod Genet       Date:  2012-05-30       Impact factor: 3.412

Review 4.  Candidate Gene, Genome-Wide Association and Bioinformatic Studies in Pre-eclampsia: a Review.

Authors:  Semone Thakoordeen; Jagidesa Moodley; Thajasvarie Naicker
Journal:  Curr Hypertens Rep       Date:  2018-08-29       Impact factor: 5.369

Review 5.  A potential pathophysiological role for galectins and the renin-angiotensin system in preeclampsia.

Authors:  Sandra M Blois; Ralf Dechend; Gabriela Barrientos; Anne Cathrine Staff
Journal:  Cell Mol Life Sci       Date:  2014-09-06       Impact factor: 9.261

6.  A novel rodent model of pregnancy complications associated with genetically determined angiotensin-converting enzyme (ACE) activity.

Authors:  Eugenia Mata-Greenwood; Arlin B Blood; LeeAnna D Sands; Shannon L Bragg; Daliao Xiao; Lubo Zhang
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-01-23       Impact factor: 4.310

7.  RNA interference therapeutics targeting angiotensinogen ameliorate preeclamptic phenotype in rodent models.

Authors:  Nadine Haase; Donald J Foster; Mark W Cunningham; Julia Bercher; Tuyen Nguyen; Svetlana Shulga-Morskaya; Stuart Milstein; Sarfraz Shaikh; Jeff Rollins; Michaela Golic; Florian Herse; Kristin Kräker; Ivo Bendix; Meray Serdar; Hanna Napieczynska; Arnd Heuser; Alexandra Gellhaus; Kristin Thiele; Gerd Wallukat; Dominik N Müller; Babbette LaMarca; Ralf Dechend
Journal:  J Clin Invest       Date:  2020-06-01       Impact factor: 14.808

8.  Expression of the renin-angiotensin system in a human placental cell line.

Authors:  Nan Pan; Wayne L Frome; Richard A Dart; Duane Tewksbury; Jiangming Luo
Journal:  Clin Med Res       Date:  2012-09-20

9.  Preeclampsia/Eclampsia candidate genes show altered methylation in maternal leukocytes of preeclamptic women at the time of delivery.

Authors:  Wendy M White; Zhifu Sun; Kristi S Borowski; Brian C Brost; Norman P Davies; Carl H Rose; Vesna D Garovic
Journal:  Hypertens Pregnancy       Date:  2016-04-11       Impact factor: 2.108

10.  Reducing stillbirths: prevention and management of medical disorders and infections during pregnancy.

Authors:  Esme V Menezes; Mohammad Yawar Yakoob; Tanya Soomro; Rachel A Haws; Gary L Darmstadt; Zulfiqar A Bhutta
Journal:  BMC Pregnancy Childbirth       Date:  2009-05-07       Impact factor: 3.007

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.